{"DataElement":{"publicId":"3912796","version":"1","preferredName":"Patient Prostate Gland Malignant Neoplasm Pathology T Stage Clinical Trial Eligibility Criteria Stage","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer for eligibility and stratification","longName":"Pt_Pros_MN_CTEC_St","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3912776","version":"1","preferredName":"Patient Prostate Gland Malignant Neoplasm Pathology T Stage Clinical Trial Eligibility Criteria","preferredDefinition":"Information related to pathologic T stage for prostate tumor for eligibility criteria","longName":"Pati_Pros_Mali_Path_T St_Clin","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3912774","version":"1","preferredName":"Prostate Gland Malignant Neoplasm Pathology T Stage Clinical Trial Eligibility Criteria","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural functional changes that result from disease processes.  Informally used to mean the result of such an examination.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"3912774v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathology","conceptCode":"C18189","definition":"The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B30090-206A-6AF7-E040-BB89AD4362D8","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"ONEDATA","dateModified":"2013-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B30090-207B-6AF7-E040-BB89AD4362D8","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3912792","version":"1","preferredName":"Patient Protstate Malignant Neoplasm Clinical Trial Eligibility Criteria Stage","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer for eligibility and stratification","longName":"Pt_Pros_Mal_Neo_Cl_Tr_El_Ct_St","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pT2 and margin negative","valueDescription":"pT2 Stage Finding And Margin Negative","ValueMeaning":{"publicId":"3912794","version":"1","preferredName":"pT2 Stage Finding And Margin Negative","longName":"3912794v1.00","preferredDefinition":"A pathologic primary tumor TNM finding. The definition of pT2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.)_An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A boundary line or the area immediately inside the boundary._Involving disadvantage or harm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT2 TNM Finding","conceptCode":"C48764","definition":"A pathologic primary tumor TNM finding. The definition of pT2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Margin","conceptCode":"C25563","definition":"A boundary line or the area immediately inside the boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B3346A-AECE-CF7F-E040-BB89AD435648","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7B3346A-AEE7-CF7F-E040-BB89AD435648","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"ONEDATA","dateModified":"2013-10-01","deletedIndicator":"No"},{"value":"All Others","valueDescription":"All Other","ValueMeaning":{"publicId":"3912795","version":"1","preferredName":"All Other","longName":"3912795","preferredDefinition":"To a complete degree or to the full or entire extent.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"All","conceptCode":"C64916","definition":"To a complete degree or to the full or entire extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B3346A-AEF4-CF7F-E040-BB89AD435648","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7B3346A-AF0D-CF7F-E040-BB89AD435648","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"ONEDATA","dateModified":"2013-10-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B3346A-AEB4-CF7F-E040-BB89AD435648","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":"2023.9.1 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171063","version":"1","longName":"RTOG-0534","context":"NRG"}]}],"AlternateNames":[{"name":"Pt_Pros_MN_CTEC_St","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Specify Pathology Stage","type":"Preferred Question Text","description":"Specify Pathology Stage","url":null,"context":"CTEP"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B3346A-AF27-CF7F-E040-BB89AD435648","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-01","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}